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Background {#ams2365-sec-0004}
==========

Patients infected with influenza A(H1N1)pdm09 virus have been reported to experience symptoms much more severe than those caused by other seasonal influenza viruses.[1](#ams2365-bib-0001){ref-type="ref"}, [2](#ams2365-bib-0002){ref-type="ref"}, [3](#ams2365-bib-0003){ref-type="ref"} Previous research suggested that venovenous extracorporeal membrane oxygenation (vvECMO) is useful for patients who are refractory to conventional therapy.[4](#ams2365-bib-0004){ref-type="ref"}, [5](#ams2365-bib-0005){ref-type="ref"} To improve the quality of pediatric vvECMO management, it is important to prepare essential equipment and protocols and to develop an education and training program.[7](#ams2365-bib-0007){ref-type="ref"}, [8](#ams2365-bib-0008){ref-type="ref"}, [9](#ams2365-bib-0009){ref-type="ref"} We report a pediatric case of influenza A(H1N1)pdm09 infection that showed a good outcome following rapid initiation of vvECMO.

Case {#ams2365-sec-0005}
====

The patient was a 13‐year‐old boy who was 148 cm in height and weighed 46 kg. He presented with high fever, disturbance of consciousness, and respiratory distress. He had no medical history of immunosuppression and no developmental delay. He was transferred to our emergency center 14 h after exhibiting fever. His Glasgow Coma Scale score was E1V1M4. He was tachypneic with a respiration rate of 40 breaths/min. Oxygenation was impaired, with an SpO~2~ of 93% on oxygen at a flow rate of 10 L/min. His heart rate was 133 b.p.m. The patient underwent tracheal intubation.

Laboratory results were 27,840/μL for leucocytes, 7.09 mg/dL for C‐reactive protein, 1.53 for prothrombin time -- international normalized ratio, 47.5 s for activated partial thromboplastin time, 7.4 μg/mL for fibrin degradation products, and 2.7 μg/mL for [d]{.smallcaps}‐dimer. Blood gas analysis revealed pH 7.05, PaCO~2~ 109 mmHg, PaO~2~ 84 mmHg, $\text{HCO}_{3}^{-}$ 28.8 mmol/L, and lactate 1.6 mmol/L. Bilateral consolidation and left pneumothorax were observed on the chest X‐ray and computed tomography (CT) (Fig. [1](#ams2365-fig-0001){ref-type="fig"}). The brain CT scan was suggestive of cerebral edema. Electroencephalography revealed that reaction to stimulation was weak, and theta waves were present. An electrocardiogram revealed ST‐segment elevation in leads V4--6, II, III, and aVF. Echocardiography showed no abnormal findings. He tested positive for influenza A virus, and he had not been previously vaccinated against influenza.

![Imaging findings at hospital admission of a 13‐year‐old boy with severe acute respiratory distress syndrome. A, Chest and abdominal X‐ray. B, Chest computed tomography (CT). C, Brain CT.](AMS2-5-390-g001){#ams2365-fig-0001}

Under the mechanical ventilation (MV) setting (synchronized intermittent mandatory ventilation mode: peak inspiratory pressure/positive end expiratory pressure 32/12 cmH~2~O; ventilation rate 20/min; F~I~O~2~ 1.0), the total and minute volumes were 3 mL/kg and 1.3 L/min, and the lung compliance was 65--75 mL/cmH~2~O. The oxygenation index and P~a~O~2~/F~I~O~2~ ratio were 24 and 84, respectively. Moreover, the patient had a pH level of \<7.25 with a P~a~CO~2~ of \>60 mmHg, which is one of the criteria for the initiation of ECMO in the EOLIA trial.[10](#ams2365-bib-0010){ref-type="ref"} The air leakage from the thoracic drain inserted for the left pneumothorax continued. The patient had a Murray score of 3.3 and was diagnosed with the Berlin definition of severe acute respiratory distress syndrome and severe air leak syndrome. According to the Pediatric Index of Mortality 2, the predicted mortality was 16.7%. His acute respiratory distress syndrome was difficult to treat using conventional therapy. Puncture for the cannula began 67 min after hospital admission, and vvECMO management was rapidly initiated within 90 min after hospital admission and required 23 min to complete.

A vvECMO cannula was punctured and inserted under real‐time ultrasound guidance in our angiography room. For blood return, an 18‐Fr, 15‐cm cannula (Flexmate, Toyobo Ltd, Osaka, Japan) was inserted in the right internal jugular vein and advanced into the right atrium. For blood drainage, a 22‐Fr, 52‐cm cannula (Flexmate) was inserted in the right femoral vein and advanced into the inferior vena cava.

A centrifugal pump was used. The pump and gas flow rates were to 80--100 mL/kg/min and F~I~O~2~, 1.0, respectively. Anticoagulant therapy involved the continuous i.v. injection of heparin targeting an activated clotting time level of 180--200 s. During vvECMO management, the MV setting was adjusted targeting SaO~2~ ≥75% and PaCO~2~ \<60 cmH~2~O. Within 12 h after the initiation of vvECMO, the MV setting needed adjustment because the control by vvECMO was insufficient for oxygenation and ventilation (Fig. [2](#ams2365-fig-0002){ref-type="fig"}). We continued continuous renal replacement therapy from day 1 to 5 because the patient developed oliguria and his metabolic acidosis had progressed. Peramivir (10 mg/kg/day) was given for 3 days. Due to the risk of developing bacterial infection and/or encephalitis, prophylactic antibiotics (ceftriaxone 60 mg/kg/day + clindamycin 25 mg/kg/day), steroid pulse (30 mg/kg/day), and immunoglobulin (150 mg/kg/day) were given for 3 days. The results of reverse transcription--polymerase chain reaction at admission yielded influenza A(H1N1)pdm09 virus.

![Clinical course of a 13‐year‐old boy with severe acute respiratory distress syndrome from day 1 to 10 of his intensive care unit (ICU) stay while being treated with venovenous extracorporeal membrane oxygenation (vvECMO). The top part of this figure shows the ventilator settings (mode, peak inspiratory pressure \[PIP\], and respiratory rate \[RR\]) and duration of ECMO and continuous renal replacement therapy (CRRT). The middle part of the figure shows medication doses. The bottom part shows changes in vital signs, PaCO~2~ level, pH level, oxygenation index, and P~a~O~2~/F~I~O~2~ (P/F) ratio. ABPC/SBT, Ampicillin/Sulbactam; APRV, airway pressure release ventilation; CLDM, Clindamycin; CTRX, Ceftriaxone; HR, heart rate; MV, mechanical ventilation; PEEP, positive end expiratory pressure; PS, pressure support; sBP, systolic blood pressure; SIMV, synchronized intermittent mandatory ventilation; VCM, Vancomycin.](AMS2-5-390-g002){#ams2365-fig-0002}

The patient was weaned from vvECMO on day 5 and MV on day 9. He was discharged from the intensive care unit on day 10. He was discharged to home on day 20 with a Pediatric Cerebral Performance Category score of 1.

Discussion {#ams2365-sec-0006}
==========

Similar to previous research, this case report reaffirms that vvECMO is useful for a patient refractory to conventional therapy. An emergency center should accept critically ill patients regardless of age. Therefore, these centers should develop a system of vvECMO management for children. Prompt vvECMO introduction may be required because respiratory insufficiency can rapidly worsen, as in our case.[6](#ams2365-bib-0006){ref-type="ref"}

Our center prepared the following systems for rapid pediatric vvECMO introduction:

Essential equipment and protocols for pediatric vvECMO.

*Cannulation technique*: The blood drainage cannula is inserted in the internal jugular vein if the patient weighs ≤30 kg and in the femoral vein if the patient weighs \>30 kg. The blood return cannula is inserted in the internal jugular vein regardless of body weight. The cannula size and insertion length in children vary with body weight (Table [1](#ams2365-tbl-0001){ref-type="table"}). Because neonates or infants rarely undergo vvECMO in the emergency center, it is not cost‐effective to stock several cannula sizes, especially smaller sizes for neonates or infants. Therefore, we substitute hemodialysis catheters for vvECMO cannulas in patients weighing \<5 kg.

###### 

Cannula size and insertion length in children according to body weight, as used at Yokohama City University Hospital (Yokohama, Japan)

  Body weight (kg)   Cannula size (Fr)/insertion length (cm)                                       
  ------------------ ----------------------------------------- ------------------------------ ---- -----------------------------
  \<3                8                                         11.5 (internal jugular vein)   6    6.5 (internal jugular vein)
  3--5               10                                        8                                   
  5--10              12                                        10                                  
  10--15             14                                        12                                  
  15--30             18                                        55 (femoral vein)              14   15 (internal jugular vein)
  \>30               20                                        18                                  

John Wiley & Sons, Ltd

*Management technique*: We use collateral flow for children weighing \<10 kg to stabilize vvECMO flow in order to avoid the need to lower the pump frequency while using a centrifugal pump. Collateral flow acts an as AV shunt (the pathway from postoxygenator to prepump). If a patient weighs \<15 kg, we undertake blood priming.

Education and training program.

Because few pediatric patients undergo ECMO, on‐the‐job experience is limited. Several reports indicated that a simulation training program effectively provided a standardized education experience for all members of an ECMO care team.[7](#ams2365-bib-0007){ref-type="ref"}, [8](#ams2365-bib-0008){ref-type="ref"}, [11](#ams2365-bib-0011){ref-type="ref"} A future need for our hospital is the development of a simulation training program for pediatric ECMO.

A previous study found an association between higher hospital ECMO volume and lower mortality.[9](#ams2365-bib-0009){ref-type="ref"} When the duration of ECMO management is predictably prolonged for a pediatric patient, transfer to another hospital with high‐volume pediatric ECMO management will be considered to improve the outcome.

Conclusion {#ams2365-sec-0007}
==========

It is essential to prepare a system enabling the rapid initiation and management of ECMO for children in the emergency center.
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